Project Grant R01DE033864
Award Date
9/20/24
Completion Date
6/30/29
Dollars Obligated
$2.7M
Federal Agency
National Institute of Dental and Craniofacial Research
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) provides $515,812 to The Johns Hopkins University to study the progression of HPV-related oropharynx cancer (HPV-OPC) and how it differs between individuals with and without HIV. The study aims to: 1) characterize the impact of HIV on oral HPV16 persistence, 2) evaluate the performance of oral and blood biomarkers for...
This $598,940 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) aims to characterize the longitudinal events of oral high-risk human papillomavirus (OHR-HPV) infection among an at-risk population of non-heterosexual males living with or without HIV in Nigeria. The primary objectives are to: 1) determine the association between HIV clinical markers, oral-anogenital contact, and...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research (CFDA 93.121) program, is supporting research to investigate the role of antiretroviral therapy (ART) in susceptibility to oral human papillomavirus (HPV) infection. The $1,913,543 award to Louisiana State University Health Sciences Center New Orleans will fund a 5-year study with three specific aims: 1) comparing the prevalence and incidence of...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $2,803,617.00 in funding to Emory University to study the intersection of HIV-related periodontitis and antiretroviral therapy-induced immune reconstitution bone loss in people living with HIV. The research aims to investigate how these two conditions, which can both lead to alveolar bone and tooth loss, impact oral...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health (CFDA 93.121 Oral Diseases and Disorders Research), provides $2,764,816 to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, from August 1, 2024 to April 30, 2029. The goal of this research is to better understand how differences in the HPV oncoprotein function contribute to therapy...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) to the University of Arizona in the amount of $118,763 for the period of September 1, 2024 to August 31, 2026. The grant will support Dr. Robert Jackson's research focused on assessing the role of human papillomavirus type 16 (HPV16) in transforming versus productive infections in oral epithelial tissues. The research aims to characterize the viral...
This Cooperative Agreement award, valued at $638,903.00, was granted by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The goal of the project is to validate a novel prognostic biomarker that captures tumor biology and heterogeneity in over 1,000 diverse human papillomavirus positive (HPV+) oropharyngeal cancer (OPC) patients across the United States, Europe, and South America. This research aims to guide...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $492,000 to evaluate the feasibility and acceptability of using mail-delivered sample collection kits to test for oral HPV DNA infection among a diverse cohort of sexual minority men living with HIV. The 2-year study will assess the agreement between at-home self-collected samples and clinic-collected samples for...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), part of the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $2,942,347 to the Regents of the University of Michigan to investigate the role of HPV integration structures in head and neck squamous cell carcinoma (HNSCC) over a 5-year period from August 2024 to April 2029. The University of Michigan will leverage a novel HPV integration analysis technology to study the...
This $157,500 Project Grant award, funded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), will support a one-year longitudinal study of the oral microbiome changes in HIV-exposed uninfected (HEU), HIV-positive, and HIV-unexposed uninfected children aged 3-4 years in Kisumu County, Kenya. The study will collect and analyze 1,080 oral swab samples from 360 children to compare the oral microbiome development...